Coronavirus Update: Gilead Says 'Inappropriate Characterizations' In Remdesivir Trial Flop Leak

Plus: J&J Finds Manufacturing Partner, AZ To Investigate Heart Complications

 
• By Scrip Team
  
Vials_Remdesivir
Three Phase III readouts are expected in the next few weeks, which should provide a clearer picture on remdesivir
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip